Q4 2024 · 13F-HR
Alerce Investment Management, L.P.holdings as filed
Filed 2025-02-14 · accession 0000895345-25-000069
$56.8M
Reported value
5
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03589W102 | ANNX | ANNEXON INC | $38.0M | 66.9% | 7,406,024 | Common | SOLE |
| 00972D105 | AKBA | AKEBIA THERAPEUTICS INC | $10.9M | 19.2% | 5,747,906 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $4.1M | 7.19% | 88,000 | Common | SOLE |
| 03044L204 | AMWL | AMERICAN WELL CORP | $3.8M | 6.69% | 523,785 | Common | SOLE |
| 00032Q104 | WHWK | AADI BIOSCIENCE INC | $2,079 | 0.00% | 659 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.